Supply Chain Intelligence
Tap into unmatched intelligence across millions of drug supply chains – from the manufacturing of key starting materials and APIs to finished dosage, all the way to the markets where a drug is sold.
Understand the supply chain of any drug. Here’s how QYOBO works.
QYOBO offers unmatched visibility across millions of pharma supply chains and 10,000+ manufacturing sites worldwide – from key starting materials to finished drugs and the markets where they are sold – so you can spot risks, and act on opportunities with confidence.
Gain unprecedented visibility into the pharma supply network – from key starting materials and APIs to finished dosage and marketing authorizations. Spanning 10,000+ manufacturing sites worldwide, QYOBO maps how drugs are made and where they are shipped, while revealing supplier relationships and dependencies such as single-sourcing or geopolitical risk – delivering unmatched clarity across your supply chain and the competition.
Stay ahead as QYOBO links supply chain intelligence with global news and events. From shutdowns, GMP non-compliance, inspections, and regulatory approvals to acquisitions, recalls, and geopolitical shocks – QYOBO instantly shows how these events impact products and markets.
QYOBO visualizes shortages directly in the supply chain, highlighting bottlenecks and vulnerabilities. Pick any product and instantly see how diversified or fragile its supply network is – and gauge how quickly competitors can recover. This gives you the confidence to act early, secure supply, and capture market opportunities.
Instantly see what each site manufactures, who owns it, and who buys from it, with details on capabilities, compliance history, inspection tracking and regulatory approvals.
Track marketing authorizations across 60+ countries and instantly reveal the full supply chain for any product. Identify shared API or FDF sites across companies, and track how new entrants or product withdrawals reshape competition and supply risks – all updated automatically, so you’re always acting on the latest intelligence.
Benefits
While Others Drown in Data, You’re Already Making the Right Moves.
Understand pharma supply chains from key starting materials and APIs to finished drugs and the markets they serve. Spanning 10,000+ manufacturing sites worldwide, QYOBO uncovers dependencies, risks, and opportunities with precision, depth, and scale unmatched in the industry.
Know exactly which sites manufacture what, who owns them, and who buys from them. With compliance tracking across all major regulators, you can identify fragile networks, anticipate disruptions, and assess resilience — turning hidden weaknesses into actionable insights before cracks show.
Success Story
“QYOBO improves our sourcing decisions and negotiations by reducing manual tasks, driving savings, and cutting costs. It has been key to staying competitive and agile in the market.”
Tommaso Bindi
Category Manager APIs – EMENA Procurement Team
More capabilities
One Platform. From Insight to Action.
See how QYOBO transforms pharma decision-making with AI-driven insights.
Questions?
Answers to your questions on how QYOBO’s Intelligence on Global Drug Shortages drives better pharma decisions.
Let’s be honest – internal data is rarely clean or connected. And even if it were, it would still be limited to your own supply chains. When a disruption becomes public, teams often struggle to identify which products a site makes or whether it affects them – let alone trace the API manufacturer behind their CMO or the source of key starting materials.
QYOBO goes far beyond internal systems by drawing on 300+ databases and millions of datasets to reconstruct the global pharma supply network. The result: a clearer view of your own supply chain than you have internally, plus the same level of insight into competitors’ networks — a unique competitive advantage, unrivaled in the market.
In most companies, it takes two to four weeks to assess the impact of a disruption. Teams dig through internal databases, ask suppliers, and coordinate across procurement, supply chain, quality, and commercial – a slow, fragmented process that often leaves you reacting too late and with limited knowledge.
QYOBO changes that by covering the entire information value chain. Within hours of an event occurring, the platform proactively alerts you and delivers the full impact analysis in seconds – showing which sites are affected, what products they make, whether they’re yours, and which competitors and markets will feel the effect. Instead of pulling data together manually, information is pushed to you – and everyone works from the same comprehensive dataset. The result: faster, more confident decisions.
QYOBO prides itself on the quality and accuracy of the intelligence we deliver – actionable insights you can trust. We know where to source raw information across the vast landscape of databases in the Pharma industry, which sources are reliable, and how to combine them effectively. Our experts understand the pitfalls, such as package leaflets that list only the batch-releasing site rather than the actual manufacturer, and have codified this knowledge into a proprietary 10-stage supply chain algorithm, with multiple logical sub-steps in each stage, built on deep domain expertise. Developed in close collaboration with clients, QYOBO provides the accuracy pharma leaders rely on to guide their response to compliance and shortage events.
Our coverage spans all major pharma regions, from Brazil, Europe, and the US to China, Saudi Arabia, and markets across Africa. Powered by a continuously updated data stream from 300+ sources, including regulatory filings, inspection reports, market authorizations, and even package leaflets, QYOBO captures everything publicly available and keeps expanding. Validated and trusted by industry leaders, it provides the most comprehensive and reliable view of the global pharma supply network.
